Drugs / 11C-YJH08
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04927663 | Aug 2021 → Feb 2025 | prostate carcinoma | Rahul Aggarwal | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 11C-YJH08 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04927663 ↗ |
| Modality | Small molecule | “11C-YJH08 is a small-molecule radiotracer” NCT04927663 ↗ |
| Route | Intravenous | “11C-YJH08 intravenously (IV) over 1-2 minutes” NCT04927663 ↗ |